| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.002 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |